CLINICAL_TRIALS
trial_result
· 2025-06-29
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（PNH） [Phase 2]
Summary
Phase 2 clinical trial evaluating the efficacy and safety of HSK39297 in patients with paroxysmal nocturnal hemoglobinuria has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 | Status: COMPLETED